Editas Medicine
Gene editing treatments development
- B2B
About Editas Medicine
A clinical stage genome editing company focused on using CRISPR technology to develop transformative treatments for serious diseases worldwide
Key facts
- Industry
- Biotechnology Research
- Company size
- 51–250 employees
- Headquarters
- cambridge, massachusetts, United States
- Founded
- 2013
- Revenue
- $40.5MFY2025, publicly reported
- Website
- editasmedicine.com
Editas Medicine at a glance
Editas Medicine is a B2B company in the Biotechnology Research industry, headquartered in cambridge, massachusetts, United States.
Editas Medicine was founded in 2013.
Editas Medicine has 51–250 employees.
Editas Medicine's revenue is $40.5M (FY2025, publicly reported).
Selling to companies like Editas Medicine?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies